Top Page
CIMG
(NASDAQ:IMG)
CIMG (IMG) vs. SPDR S&P 500 ETF (SPY)
CIMG Business Overview & Revenue Model
CIMG Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.93M | 3.35M | 3.11M | 1.93M | 1.40M |
| Gross Profit | 32.17K | 8.82K | -110.41K | -80.09K | -238.95K |
| EBITDA | -9.20M | -8.65M | -11.02M | -17.91M | -8.93M |
| Net Income | -8.56M | -8.75M | -11.80M | -18.55M | -9.48M |
Balance Sheet | |||||
| Total Assets | 5.90M | 4.44M | 11.71M | 13.74M | 8.18M |
| Cash, Cash Equivalents and Short-Term Investments | 464.22K | 1.37M | 8.32M | 10.82M | 4.40M |
| Total Debt | 3.40M | 409.23K | 722.94K | 533.30K | 872.31K |
| Total Liabilities | 5.99M | 2.77M | 1.97M | 1.53M | 1.79M |
| Stockholders Equity | -87.27K | 1.67M | 9.74M | 12.21M | 6.39M |
Cash Flow | |||||
| Free Cash Flow | -10.42M | -6.94M | -7.65M | -7.22M | -4.36M |
| Operating Cash Flow | -10.10M | -6.93M | -7.46M | -7.11M | -4.24M |
| Investing Cash Flow | -320.04K | -16.24K | -604.83K | -115.36K | -6.70K |
| Financing Cash Flow | 9.59M | -36.03K | 5.68M | 13.63M | 7.25M |
CIMG Technical Analysis
CIMG Risk Analysis
CIMG Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | £7.97B | 8.83 | 8.48% | 3.53% | 2.08% | 24.83% | |
48 Neutral | $11.29M | 0.14 | 37.38% | ― | -8.12% | ― | |
43 Neutral | $8.04M | 6.01 | -45.00% | ― | -77.72% | -282.16% | |
42 Neutral | $2.26M | 1.27 | -3.22% | ― | -49.19% | -394.71% | |
39 Underperform | $8.55M | ― | ― | -21.91% | 54.49% | ||
33 Underperform | $3.25M | ― | -286.71% | ― | ― | ― | |
| ― | $102.66M | ― | ― | ― | ― |
CIMG Corporate Events
On August 6, 2025, CIMG, Inc. appointed Ms. Feng Tian as the new Chief Financial Officer. Ms. Tian, who has been with the company since 2024 as head of finance, brings experience from previous roles at Daren International and Henan Aishan Education Corp. This leadership change is part of CIMG’s strategic efforts to strengthen its financial operations and align with its growth objectives. The appointment is formalized through an employment agreement, which includes a base salary of $12,000 annually.
On August 1, 2025, CIMG Inc.’s subsidiary, Shanghai Huomao Cultural Development Co., Ltd., launched Huomao Jiangxiang Baijiu, a premium Maotai-style liquor, on major Chinese e-commerce platforms as part of its global expansion strategy. The product, which integrates traditional Chinese medicine principles, is positioned as a health-focused baijiu and aims to reach broader consumer demographics through a multi-channel approach. The company has also initiated global partnership recruitment and appointed brand ambassadors in several countries, including Singapore, Kazakhstan, Japan, Germany, and Italy.
CIMG Inc., listed on Nasdaq under the symbol IMG, received a delist determination letter from Nasdaq on July 17, 2025, due to its failure to meet the minimum bid price requirement of $1 per share for 30 consecutive business days. The company was initially notified of this issue on January 14, 2025, and given 180 days to comply, which it failed to do by the deadline of July 14, 2025. As CIMG does not meet the initial listing requirements for The Nasdaq Capital Market, it is not eligible for an extension. The company has appealed the decision, with a hearing scheduled for August 14, 2025, where it will present its case to the Nasdaq Hearings Panel.
On July 17, 2025, CIMG Inc., known for its specialty coffee and consumer food and beverage products, announced the launch of the Huomao Global Investment Promotion Plan. This initiative includes appointing promotion ambassadors in Singapore, Kazakhstan, Japan, Germany, and North America to expand the global reach of Huomao culture. The appointments were finalized at an appreciation dinner on July 13, 2025. This strategic move is expected to support CIMG’s overseas expansion by introducing selected classic products through local distribution partners, enhancing its market presence and stakeholder engagement.
On June 27, 2025, CIMG Inc. received a delist determination letter from Nasdaq due to non-compliance with filing requirements, including the failure to submit its Form 10-K for the fiscal year ending September 30, 2024, and Forms 10-Q for subsequent periods. Despite previous exceptions granted by Nasdaq, the company did not meet the deadlines, leading to the potential suspension of its stock trading on July 9, 2025, unless an appeal is made. Additionally, CIMG faces delisting risks due to not meeting the minimum stockholders’ equity requirement, despite a previous compliance notification in July 2024. The company plans to appeal the delisting decision and aims to file the necessary reports by July 7, 2025.
CIMG Inc., a company with a heritage in specialty coffee and an emerging business in broader consumer food and beverage products, announced an Appreciation Dinner in Shanghai on July 13, 2025, to celebrate its integration with Shanghai Huomao Cultural Development Co., Ltd. This event marks the first joint occasion post-acquisition, aiming to strengthen relationships with investors, partners, and media. The event will include a red-carpet welcome, project briefing, brand ambassador signing ceremony, product tasting sessions, and live performances. Remarks will be delivered by Mr. Xiaocheng Hao, highlighting the company’s strategic vision in the dendrobium industry under the ‘Food and Medicine from the Same Origin’ philosophy.
On June 2, 2025, CIMG Inc. entered into a share purchase agreement with non-U.S. investors for a private placement of 6,000,000 shares of common stock, raising $1,068,480. The closing of this transaction occurred on June 9, 2025, increasing the total outstanding shares to 36,397,418.
On June 2, 2025, CIMG Inc. entered into a share purchase agreement with non-U.S. investors for a private placement of 6,000,000 shares of common stock, expected to close around June 9, 2025. This agreement will increase the company’s total shares to 36,397,418 and includes a Registration Rights Agreement requiring a registration statement filing by August 8, 2025, potentially impacting the company’s market presence and investor relations.
On May 19, 2025, CIMG Inc. received a notice from NASDAQ indicating non-compliance with Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of its Quarterly Report on Form 10-Q for the period ended March 31, 2025. This notice does not immediately affect the company’s stock listing on Nasdaq. The company has been granted exceptions for previous delinquent filings, with a deadline of July 14, 2025, to regain compliance. CIMG cites business and management restructuring as reasons for the delay and is working to complete its financial statements and filings with the SEC as soon as possible.